A British pensioner has drowned while trying to rescue her granddaughter from the sea on the last day of their Spanish holiday.
READ MOREUkrainian’s have been returning to their homes to see what is left after years of rocket strikes. With just the River Dnipro separating Ukrainian and Russian troops,Oleshky has been a key strategic t
Riot police clashed with protesters as they took over the Bastille Square in Paris. Officers charged the thousands of schoolchildren with batons and unleashed water cannons as they moved in to try and
Expects Adjusted Profit attributable to Owners of the Parent in 2024 toGrowby Approximately 62% to 112% YoY
Envision Energy secured contract to supply 58.5MW wind turbines for Aboitiz\'s Libmanan Wind Power Project in the Philippines.
SYDNEY,Feb. 14,2025-- Infomedia Ltd (ASX: IFM) is pleased to announce that it has entered into a binding agreement to acquire 50% of European AI startup,Intellegam GmbH (Intellegam),for a purchase pri
STOCKHOLM,Feb. 14,2025-- The shareholders of ABElectrolux (publ),reg. no. 556009-4178 (the "Company"),are hereby given notice of the Annual General Meeting to be held on Wednesday,March 26,2
Earnings Call Scheduled for 7:00 A.M. U.S. ET on March 5,2025 GUIYANG,China,Feb. 14,2025-- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM),a leading digital freig
SYDNEY,Feb. 15,2025--Roborock,a global leader in ultra-intelligent home robotics engineered to simplify daily life,today announces the Australian launch of its newest wet-dry vacuum cleaner range,the
The media powerhouse is taking over NBA All-Star weekend with exclusive content and star-studded experiences,showcasing a new era for digital entertainment
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu
SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi
© OfficialAffairs
